National

Supply order for Covishield vaccine was placed after drug regulator approved it: Govt

For the procurement of COVID-19 vaccines, a supply order dated January 11 was placed with the Serum Institute of India after Covishield was approved for restricted use in emergency situation by India's drug regulator, the Rajya Sabha was informed on Tuesday.

migrator

New Delhi

Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines.

Covishield is being manufactured by the Pune-based firm with technology transfer from AstraZeneca/Oxford University.

On whether it is a fact that multiple doses of the vaccine produced for India could not be rolled out despite approval due to the lack of a formal agreement for supply, Choubey, in a written reply, said, '' No. As per protocol, the supply order for COVID-19 vaccines, specifying the number of vaccine doses, was placed with the manufacturer and vaccines were delivered within 3 days to the states and UTs and other consignee points.''

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Fire at Chennai's BSNL office hits helplines

IUML seeks 16 seats for Muslims from DMK

TN's patent filing crosses 68K, tops nation

Bus stand on cultivable land to favour realtors, AIADMK protests in Kumbakonam

U-19 Asia Cup: India looks to extend dominance against Pakistan in final